Generate Biomedicines, Inc. — Investor Relations & Filings

Generate Biomedicines is a clinical-stage therapeutics company pioneering generative biology to create breakthrough medicines. It operates at the intersection of machine learning, biological engineering, and medicine, leveraging an AI-powered platform. This platform integrates generative and predictive models that learn design principles from millions of proteins, enabling the creation of novel medicines with specific therapeutic functions. The company designs medicines on demand across multiple therapeutic modalities, including antibodies and enzymes, aiming to fundamentally change drug discovery with enhanced speed and success rates.